THE VALUE OF GONADOTROPIN-RELEASING-HORMO NE AGONIST PRETREATMENT BEFORE TRANSCERVICAL RESECTION OF SOLITARY SUBMUCOUS MYOMAS

In a retrospective study, the value of pretreatment with a gonadotropi n-releasing-hormone (GnRH) agonist before hysteroscopic myoma resectio n was assessed in 31 patients suffering from menorrhagia. No differenc e in operating time, intra-operative fluid deficit, blood loss and pos toperative eumenorrhoea rate was found between pretreated and non-pret reated patients with solitary submucous myomas smaller than 4 cm in di ameter. Thus, pretreatment with GnRH agonists before the resection of small solitary submucous myomas has no benefit for the patients.